Clinical Trial Update: Tofacitinib in Recurrent GBM Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tofacitinib in recurrent glioblastoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Glioblastoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING